258 related articles for article (PubMed ID: 8944035)
1. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases.
Lin BT; Colby T; Gown AM; Hammar SP; Mertens RB; Churg A; Battifora H
Am J Surg Pathol; 1996 Dec; 20(12):1431-9. PubMed ID: 8944035
[TBL] [Abstract][Full Text] [Related]
2. Malignant vascular tumours of the pleura in "asbestos" workers and endothelial differentiation in malignant mesothelioma.
Attanoos RL; Suvarna SK; Rhead E; Stephens M; Locke TJ; Sheppard MN; Pooley FD; Gibbs AR
Thorax; 2000 Oct; 55(10):860-3. PubMed ID: 10992539
[TBL] [Abstract][Full Text] [Related]
3. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review.
Zhang PJ; Livolsi VA; Brooks JJ
Hum Pathol; 2000 Jan; 31(1):29-34. PubMed ID: 10665909
[TBL] [Abstract][Full Text] [Related]
4. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin expression in epithelioid vascular neoplasms.
Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid sarcoma-like hemangioendothelioma.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2003 Jan; 27(1):48-57. PubMed ID: 12502927
[TBL] [Abstract][Full Text] [Related]
7. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
Laury AR; Hornick JL; Perets R; Krane JF; Corson J; Drapkin R; Hirsch MS
Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma.
Nakashima Y; Inamura K; Ninomiya H; Okumura S; Mun M; Kirimura S; Kobayashi M; Okubo K; Ishikawa Y
Lung Cancer; 2020 Oct; 148():20-27. PubMed ID: 32777673
[TBL] [Abstract][Full Text] [Related]
9. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
11. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
12. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
Duggan MA; Masters CB; Alexander F
Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
[TBL] [Abstract][Full Text] [Related]
14. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma.
Bahrami A; Allen TC; Cagle PT
Pathol Int; 2008 Nov; 58(11):730-4. PubMed ID: 18844940
[TBL] [Abstract][Full Text] [Related]
16. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
17. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
18. Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.
Anderson T; Zhang L; Hameed M; Rusch V; Travis WD; Antonescu CR
Am J Surg Pathol; 2015 Jan; 39(1):132-9. PubMed ID: 25353289
[TBL] [Abstract][Full Text] [Related]
19. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.
Nind NR; Attanoos RL; Gibbs AR
Histopathology; 2003 Feb; 42(2):150-5. PubMed ID: 12558747
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
Wei MC; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
